Nucleic Acid Amplification Testing: The New Infectious Disease Testing Method for Donor Blood

NAT? Questions and Answers About Screening the Volunteer Donor Blood Supply with a New Research Test. America's Blood Centers Memoranda; 1998.

Schreiber G.B. , Busch M.P. , Kleinman S.H. . The risk of transfusion-transmitted viral infections. N Engl J Med. 1996; 334: 1685–1690.

Busch M.P. , Young M.J. , Samson S.M. . Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion. 1991; 31: 4–11.

Williams A.E. , Thomson R.A. , Schreiber G.B. . Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA. 1997; 277: 967–972.

Busch M.P. . Applications of molecular biology to infectious disease screening of blood donors. In: Allen R.W. , AuBuchon J.P. , eds. Molecular Genetics in Diagnosis and Research. Bethesda, Md: American Association of Blood Banks; 1995.

Nubling C.M. , Wilkommen H. , Lower J. . Hepatitis C transmission associated with intravenous immunoglobulins. Lancet. 1995; 345: 1174.

Lee H.H. , Allain J.P. . Genomic screening for blood-borne viruses in transfusion settings. Vox Sang. 1998; 74(suppl 2): 119–123.

HIV-1/HCV TMA Assay, HIV-1/HCV TMA Assay, Draft Package Insert, 5000 Test Kit, 10-28-98. Gen-Probe Inc, San Diego, Calif.

COBAS AmpliScreen HCV Test, Draft Package Insert. Roche Molecular Systems, Inc, Pleasanton, Calif.

Conry-Cantilena C. , VanRaden M. , Gibble J. . Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996; 334: 1691–1696.

Rogers P.M. , Saldhana J. , Allain J.P. . Report of EPFA/NIBSC workshop “Nucleic Acid Amplification Tests (NAT) for the Detection of Blood-Borne Viruses.” October 31, 1996, Amsterdam, The Netherlands. Vox Sang. 1997; 72: 199–206.

NAT Implementation. Bethesda, Md: American Association of Blood Banks; 1999. American Association of Blood Banks Association Bulletin #99-3.

Cardoso M.S. , Koerner K. , Kubanek B. . Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results. Transfusion. 1998; 38: 905–907.

Roth W.K. , Weber M. , Seifried E. . Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet. 1999; 353: 359–363.

Schottstedt V. , Tuma W. , Bunger G. . PCR for HBV, HCV, and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals. 1998; 26: 101–104.

Caglioti S. , Strong M. , MacPherson J. . NAT Update & Survey of NAT Testing Locations TCN 98-407.